Independently batch-tested research materials

Phase 2 Configuration – Modular Peptide Systems B+D

Product Name: Phase 2 Configuration – Modular Peptide Systems B+D Configuration Classification: Extension Framework Configuration Product Information: Configuration Type: Elevated-Concentration Comparative Framework Included Modules: B, D Total Modules: 2 System Compatibility: Topical System Framework Testing Methodology: HPLC-UV-MS Analytical Verification: ISO/IEC 17025 Accredited Laboratory Evaluation Format: Standalone Configuration or Sequential Configuration Framework Analytical Composition: Module B Total Peptide Content: 0.23% Palmitoyl Tripeptide-38 Palmitoyl Tetrapeptide-7 Gel Matrix Module D Total Peptide Content: 0.10% AHK-Cu Tocopherol (Vitamin E) Copper-Coordinated Peptide Complex Serum-Emulsion Matrix Configuration Character Two chemistry classes Two delivery matrices Two elevated-concentration peptide compositions Product Description: Phase 2 is one of three configurations within PHP’s Modular Peptide System, a modular framework of peptide formulations designed for research evaluation. Configurations represent defined combinations of individual modules (A through E) assembled to provide broader comparative frameworks than standalone module evaluation. Phase 2 combines two elevated-concentration, single-peptide-dominant compositions representing distinct chemistry classes within the modular framework: the concentrated palmitoylated peptide gel (Module B) and the copper-coordinated peptide complex (Module D). Together, these modules establish a focused framework integrating elevated peptide concentration, distinct formulation architectures, and separate chemistry classes. Each included module is independently verified through ISO/IEC 17025-accredited analytical testing using HPLC-UV-MS methodology. Batch-specific Certificates of Analysis are available through the COA-Topicals library. Research Framework: Depth-extension framework within the Modular Peptide System Two elevated-concentration peptide compositions Two distinct chemistry classes Two separate delivery matrices Focused comparative architecture Phase 2 may be evaluated independently as a depth-extension framework or sequentially alongside Phase 1 within a structured evaluation protocol. When configurations are sequenced within a 24-hour evaluation cycle, defined separation intervals (typically ~12 hours) between configurations allow the analytical contributions of each to be observed without compositional overlap. Configuration Characteristics: Combines the system’s targeted module (B) with its advanced module (D) Incorporates both free peptide and copper-coordinated peptide chemistry Includes both gel and serum-emulsion delivery systems Focuses on concentrated, single-peptide-dominant compositions Provides a narrower but deeper comparative framework than Phase 1 Introduces formulation variables not present within the foundational configuration Position Within The System: Within the Modular Peptide System framework, Phase 2 functions as the extension configuration. Whereas Phase 1 emphasizes peptide-class diversity and compositional breadth, Phase 2 focuses on elevated-concentration architectures and chemistry-class differentiation. Together, the two modules establish…

Research areas: Dermal, Hair & Tissue Appearrance

Search the Certificate of Analysis library for batch-specific test documentation.